Research Firm CEO Who Interacted with FDA on Company’s Behalf Also Charged The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and...
Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced that the U.S. Food and Drug Administration (FDA) has renewed its...